General Announcement::Board Meeting Intimation

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
30-Jul-2018 19:26:49
Status
New
Announcement Sub Title
Board Meeting Intimation
Announcement Reference
SG180730OTHRT3OB
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary Compliance Officer
Effective Date and Time of the event
30/07/2018 16:00:00
Description (Please provide a detailed description of the event in the box below)
We have to inform you that, pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors will be held on Friday, August 10, 2018, inter alia, to consider and approve the Unaudited Financial Results of the Company for the First Quarter ended June 30, 2018.

Further, as per the "Code of Conduct for Prevention of Insider Trading" and pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 the Company has intimated its Directors and other designated persons regarding the closure of trading window from July 1, 2018 to August 12, 2018 (both days inclusive) for the purpose of approval of Unaudited Financial Results for the First Quarter ended June 30, 2018.

Attachments

BM_Intimation.pdf
Total size =320K